BioNTech SE ( BNTX) - Key Metrics
BNTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.42 | -$3.29 | $0.04 | -$0.18 |
| 2026Q1 | $0.47 | -$2.14 | -$1.69 | -$1.92 |
| 2025Q4 | $3.67 | -$1.23 | $1.22 | $0.97 |
| 2025Q3 | $6.35 | -$0.12 | $3.57 | $3.39 |
| 2025Q2 | $1.08 | -$1.60 | $0.55 | $2.90 |
BNTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -6.17 |
| 2026Q1 | 0% | -8.98 |
| 2025Q4 | 0% | -16.47 |
| 2025Q3 | 0% | -175.05 |
| 2025Q2 | 0% | -14.12 |
BNTX
Price: $96.96
52 week price:
Payout Ratio Range:
Earnings Per Share: -7.68 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Germany
Volume: 379200
Market Capitalization: 24.0 billion